Tuesday, October 15, 2019 9:10:24 AM
GeoVax Presenting at Upcoming October European Scientific Conferences
GeoVax Presenting at Upcoming October European Scientific Conferences
GlobeNewswire•October 15, 2019
Unique Platform Continues to be Recognized for Distinct Benefits
ATLANTA, GA, Oct. 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (GOVX), a biotechnology company specializing in developing human vaccines, announced today that it will be represented during presentations at the following upcoming European scientific conferences.
Festival of Biologics / World Immunotherapy Congress, Basel, Switzerland, Oct. 15-17
Farshad Guirakhoo, PhD, GeoVax Chief Scientific Officer, will deliver an oral presentation entitled, Utilizing a Live Modified Vaccinia Ankara Virus to Deliver Cancer Antigens in Highly Immunogenic Forms of Virus Like Particles. In this talk, Dr. Guirakhoo will illustrate advantages of the inherently safe MVA-VLP platform to deliver “cancer like MUC1” antigens designed to break the host tolerance against MUC1 and train the body’s own immune system to attack and kill cancer cells.
International Society for Virology (ISV), 2019 Annual Congress, Ghent, Belgium, Oct. 27-29
During this conference, Dr. Guirakhoo will deliver an oral presentation entitled, Development of Single Dose Vaccines against Emerging and Reemerging Infectious Diseases Using a Novel MVA-VLP Vector. In this talk, latest data for Ebola, Marburg, Lassa and Zika vaccines, pathogens selected from three different families of viruses, will demonstrate broad utility of GeoVax’s vector platform for developing safe and effective single-dose vaccines for many known emerging and re-emerging infectious diseases.
World Vaccine Congress-Europe, Barcelona, Spain, Oct. 29-31
During this conference, Dr. Guirakhoo will deliver an oral presentation entitled, MVA-VLP as a safe and effective platform for delivery of multi-antigen vaccine candidates for infectious diseases and cancer. In this talk, the most relevant vaccine safety and efficacy data, including characterization of humoral and T cell responses, for selected viral infectious disease targets will be presented as examples for a broad utility of the platform for other indications such as malaria, HPV, HBV and cancer immunotherapy.
Commenting on these presentations, David Dodd, GeoVax CEO, stated, “We are pleased in the continued and increasing recognition of the GeoVax MVA-VLP technology and expertise, ranging from immuno-oncology to various infectious diseases. Such invited presentations provide us the opportunity to further underscore the potential value of our developments focused on improving the lives of millions worldwide, while also progressing our collaboration discussions with both public and private organizations.”
/bhttps://finance.yahoo.com/news/geovax-presenting-upcoming-october-european-130000356.html
Recent GOVX News
- GeoVax to Participate in Upcoming Investor Conferences in September • GlobeNewswire Inc. • 09/03/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:15:02 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/30/2024 01:38:39 PM
- GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-Market • GlobeNewswire Inc. • 08/29/2024 12:59:18 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/21/2024 08:19:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/21/2024 01:22:03 PM
- Registration is Now Open for Tribe Public’s Webinar Event "Now Is Not the Time to Monkey(pox) Around" Featuring GeoVax Lab’s CEO • GlobeNewswire Inc. • 08/21/2024 01:00:00 PM
- GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-Market • GlobeNewswire Inc. • 08/20/2024 11:45:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:12:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:11:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:10:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:10:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:09:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:09:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:08:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:07:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:07:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:06:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2024 08:06:04 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 08/13/2024 04:15:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/12/2024 12:47:49 PM
- GeoVax Appoints Teresa Lambe, Acclaimed Professor of Vaccinology and Immunology at the Oxford Vaccine Group, to Its Scientific Advisory Board • GlobeNewswire Inc. • 08/08/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:05:39 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/06/2024 09:17:09 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/06/2024 09:16:20 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM